StonvexLoading…
StonvexCore line items from FTDR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.09B | $1.84B | $1.78B | $1.66B |
Operating Income | $338.00M | $309.00M | $229.00M | $93.00M |
Net Income | $255.00M | $235.00M | $171.00M | $71.00M |
EPS (Diluted) | $3.42 | $3.01 | $2.12 | $0.87 |
Total Assets | $2.14B | $2.11B | $1.09B | $1.08B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $566.00M | $421.00M | $325.00M | $292.00M |
Free Cash Flow OCF − CapEx | $390.00M | $231.00M | $170.00M | $102.00M |
Shares Outstanding | 70.96M | 75.31M | 78.38M | 81.52M |